Determination of celiprolol in human plasma using high performance liquid chromatography with fluorescence detection for clinical application

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 904, Issue , 2012, Pages 88-92

  Itohda, Akiko ^a   Tsutsumi, Kimiko ^a   Imai, Hiromitsu ^a   Iwao, Miyuki ^a   Kotegawa, Tsutomu ^a   Ohashi, Kyoichi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Apple juice; Celiprolol; Fluorescence detection; HPLC; Solid phase extraction

Indexed keywords

APPLE JUICE; CELIPROLOL; FLUORESCENCE DETECTION; HPLC; SOLID-PHASE EXTRACTION;

ACETONITRILE; AMMONIUM COMPOUNDS; FRUIT JUICES;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ACEBUTOLOL; CELIPROLOL;

ACCURACY; ANALYTIC METHOD; APPLE JUICE; AREA UNDER THE CURVE; ARTICLE; CALIBRATION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; FLUORESCENCE; FOOD DRUG INTERACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION;

AREA UNDER CURVE; BEVERAGES; CELIPROLOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; FRUIT; HERB-DRUG INTERACTIONS; HUMANS; LINEAR MODELS; MALUS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; SPECTROMETRY, FLUORESCENCE;

MALUS X DOMESTICA;

EID: 84865388536     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.07.026     Document Type: Article

References (21)

1. Miline R.J., Buckley M.M. Drugs 1991, 41:941.
2. Karlsson J., Kuo S.-M., Ziemniak J., Artursson P. Br. J. Pharmacol. 1993, 110:1009.
3. Ho R.H., Kim R.B. Clin. Pharmacol. Ther. 2005, 78:260.
4. Lilja J.J., Backman J.T., Laitila J., Luurila H., Neuvonen P.J. Clin. Pharmacol. Ther. 2003, 73:192.
5. Lilja J.J., Juntti-Patinen L., Neuvonen P.J. Clin. Pharmacol. Ther. 2004, 75:184.
6. Kato Y., Miyazaki T., Kano T., Sugiura T., Kubo Y., Tsuji A. J. Pharm. Sci. 2009, 98:2529.
7. Ieiri I., Doi Y., Maeda K., Sasaki T., Kimura M., Hirota T., Chiyoda T., Miyagawa M., Irie S., Iwasaki K., Sugiyama Y. J. Clin. Pharmacol. 2012, 52:1078.
8. Bailey D.G. Br. J. Clin. Pharmacol. 2010, 70:645.
9. Imanaga J., Kotegawa T., Imai H., Tsutsumi K., Yoshizato T., Ohyama T., Shirasaka Y., Tamai I., Tateish T., Ohashi K. Pharmacogenet. Genomics 2011, 21:84.
10. Rutledge D.R., Abadi A.H., Lopez L.M. J. Chromatogr. Sci. 1994, 32:153.
11. Verbesselt R., Zugravu A., Tjandramaga T.B., De Schepper P.J. J. Chromatogr. B 1996, 683:231.
12. Braza A.J., Modamio P., Marino E.L. J. Chromatogr. B 1998, 718:267.
13. Hartmann C., Krauss D., Spahn H., Mutschler E. J. Chromatogr. 1989, 496:387.
14. Chiu F.C.K., Raymond K. J. Chromatogr. B 1996, 687:462.
15. Delamoye M., Duverneuil C., Paraire F., de Mazancourt P., Alvarez J.-C. Forensic Sci. Int. 2004, 141:23.
16. Caudron E., Laurent S., Billaud E.M., Prognon P. J. Chromatogr. B 2004, 801:339.
17. Minamide Y., Osawa Y., Nishida H., Igarashi H., Kudoh S. J. Sep. Sci. 2011, 34:1590.
18. F.D.A. Guidance for Industry: Biomedical Method Validation 2001, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation (CDER) and Research & Center for Veterinary Medicine (CVM). http://www.fda.gov/cder/guidance/4252fnl.pdf.
19. Yoshizato T., Kotegawa T., Imai H., Tsutsumi K., Imanaga J., Ohyama T., Ohashi K. Eur. J. Clin. Pharmacol. 2012, 10.1177/0s00228-012-1258-x.
20. Tullo A. Chem. Eng. News 2008, 86:27.
21. Lilja J.J., Niemi M., Neuvonen P.J. Eur. J. Clin. Pharmacol. 2004, 59:819.